tag:blogger.com,1999:blog-28450497.post6304984942459207958..comments2007-07-29T13:23:19.396-04:00Adam J. Fein, Ph.D.http://www.blogger.com/profile/12217252282643255442noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-28450497.post-91377229880944163812007-07-29T13:23:00.000-04:002007-07-29T13:23:00.000-04:00The point is that in order to acheive savings in any drug program, cutting Pharmacy reimbursement in not a productive or efficient way to do it. Nor is dis-incentivizing the use of more affordable generic drugs! Cut the brand name manufacturer's prices. That is the true source of the escalating cost of drug programs. A price increase (often much higher than inflation) by the manufacturers at will, often instantly wipes out savings of a reduction to pharmacy's reimbursent which is often oppressive to the pharmacy. Pharmacy's reimbursement over and above the product cost is such a small percentage of the total program cost that cutting pharmacist reimbursement seems counterproductive and counterintuitive.Anonymousnoreply@blogger.com